Geode Capital Management’s Bolt Biotherapeutics BOLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $108K | Sell |
18,533
-223
| -1% | -$1.3K | ﹤0.01% | 4040 |
|
|
2025
Q1 | $150K | Buy |
18,756
+1,722
| +10% | +$13.8K | ﹤0.01% | 3926 |
|
|
2024
Q4 | $182K | Sell |
17,034
-587
| -3% | -$6.28K | ﹤0.01% | 3932 |
|
|
2024
Q3 | $228K | Sell |
17,621
-919
| -5% | -$11.9K | ﹤0.01% | 3863 |
|
|
2024
Q2 | $278K | Buy |
18,540
+1,162
| +7% | +$17.4K | ﹤0.01% | 3796 |
|
|
2024
Q1 | $487K | Sell |
17,378
-130
| -0.7% | -$3.64K | ﹤0.01% | 3627 |
|
|
2023
Q4 | $392K | Sell |
17,508
-529
| -3% | -$11.9K | ﹤0.01% | 3704 |
|
|
2023
Q3 | $375K | Buy |
18,037
+426
| +2% | +$8.86K | ﹤0.01% | 3713 |
|
|
2023
Q2 | $451K | Buy |
17,611
+8,711
| +98% | +$223K | ﹤0.01% | 3682 |
|
|
2023
Q1 | $247K | Buy |
8,900
+1,196
| +16% | +$33.2K | ﹤0.01% | 3942 |
|
|
2022
Q4 | $200K | Buy |
7,704
+593
| +8% | +$15.4K | ﹤0.01% | 4103 |
|
|
2022
Q3 | $210K | Hold |
7,111
| – | – | ﹤0.01% | 4182 |
|
|
2022
Q2 | $290K | Sell |
7,111
-9,224
| -56% | -$376K | ﹤0.01% | 4050 |
|
|
2022
Q1 | $895K | Sell |
16,335
-3,272
| -17% | -$179K | ﹤0.01% | 3669 |
|
|
2021
Q4 | $1.92M | Buy |
19,607
+2,351
| +14% | +$230K | ﹤0.01% | 3383 |
|
|
2021
Q3 | $4.37M | Buy |
17,256
+6,748
| +64% | +$1.71M | ﹤0.01% | 2988 |
|
|
2021
Q2 | $3.25M | Buy |
10,508
+15
| +0.1% | +$4.64K | ﹤0.01% | 3120 |
|
|
2021
Q1 | $6.91M | Buy |
+10,493
| New | +$6.91M | ﹤0.01% | 2612 |
|